CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 20 8089 7893 support@capital.com

Perdagangan OPKO Health, Inc. - OPK CFD

1.3972
2.18%
0.0256
Rendah: 1.3373
Tinggi: 1.4272
Market Trading Hours* (UTC) Open now
Closes on Thursday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0256
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.3772
Open* 1.4272
1-Year Change* -54.11%
Day's Range* 1.3373 - 1.4272
52 wk Range 1.03-3.78
Average Volume (10 days) 2.62M
Average Volume (3 months) 52.21M
Market Cap 996.77M
P/E Ratio -100.00K
Shares Outstanding 772.69M
Revenue 1.22B
EPS -0.45
Dividend (Yield %) N/A
Beta 1.69
Next Earnings Date Feb 22, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 1, 2023 1.3772 0.1098 8.66% 1.2674 1.4272 1.2575
Jan 31, 2023 1.2774 0.0399 3.22% 1.2375 1.2874 1.2375
Jan 30, 2023 1.2275 0.0000 0.00% 1.2275 1.2575 1.2175
Jan 27, 2023 1.2475 0.0300 2.46% 1.2175 1.2774 1.2076
Jan 26, 2023 1.2475 -0.0199 -1.57% 1.2674 1.2675 1.2175
Jan 25, 2023 1.2974 0.0100 0.78% 1.2874 1.3174 1.2475
Jan 24, 2023 1.3174 -0.0598 -4.34% 1.3772 1.3772 1.2774
Jan 23, 2023 1.3772 -0.0599 -4.17% 1.4371 1.4471 1.3673
Jan 20, 2023 1.4870 0.0399 2.76% 1.4471 1.5070 1.4371
Jan 19, 2023 1.4671 -0.1197 -7.54% 1.5868 1.5869 1.4571
Jan 18, 2023 1.5968 0.0000 0.00% 1.5968 1.6667 1.5769
Jan 17, 2023 1.5769 0.0200 1.28% 1.5569 1.6567 1.5070
Jan 13, 2023 1.5669 0.2396 18.05% 1.3273 1.5869 1.3174
Jan 12, 2023 1.3174 0.0300 2.33% 1.2874 1.3174 1.2774
Jan 11, 2023 1.2974 0.0299 2.36% 1.2675 1.3074 1.2575
Jan 10, 2023 1.2575 0.0300 2.44% 1.2275 1.2575 1.2275
Jan 9, 2023 1.2275 0.0000 0.00% 1.2275 1.2675 1.1976
Jan 6, 2023 1.2675 0.0400 3.26% 1.2275 1.2675 1.1876
Jan 5, 2023 1.2275 -0.0200 -1.60% 1.2475 1.2675 1.2076
Jan 4, 2023 1.2774 0.0798 6.66% 1.1976 1.2774 1.1876

OPKO Health, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 1117.49 966.006 990.266 901.935 1435.41 1774.72
Revenue 1117.49 966.006 990.266 901.935 1435.41 1774.72
Cost of Revenue, Total 611.482 620.13 604.636 572.484 894.408 1193.19
Gross Profit 506.012 345.876 385.63 329.451 541.005 581.524
Total Operating Expense 1214.05 1242.45 1161.46 1175.99 1377.7 1755.97
Selling/General/Admin. Expenses, Total 398.431 408.828 353.446 340.305 354.573 468.857
Research & Development 113.871 126.435 125.586 117.87 75.316 76.85
Depreciation / Amortization 64.407 71.484 67.933 64.783 56.391 50.278
Unusual Expense (Income) 8.9 18.994 26.678 95.399 1 -31.508
Other Operating Expenses, Total 16.954 -3.423 -16.816 -14.854 -3.989 -1.703
Operating Income -96.551 -276.442 -171.197 -274.052 57.714 18.75
Interest Income (Expense), Net Non-Operating -4.174 -5.939 -7.607 -19.632 -21.732 -18.006
Other, Net 3.903 10.457 1.535 -11.281 12.701 -14.77
Net Income Before Taxes -96.822 -271.924 -177.269 -304.965 48.683 -14.026
Net Income After Taxes -40.707 -290.779 -138.543 -312.025 31.066 -29.515
Equity In Affiliates -7.652 -14.471 -14.497 -2.9 -0.48 -0.629
Net Income Before Extra. Items -48.359 -305.25 -153.04 -314.925 30.586 -30.144
Net Income -48.359 -305.25 -153.04 -314.925 30.586 -30.144
Income Available to Common Excl. Extra. Items -48.359 -305.25 -153.04 -314.925 30.586 -30.143
Income Available to Common Incl. Extra. Items -48.359 -305.25 -153.04 -314.925 30.586 -30.143
Diluted Net Income -48.359 -305.25 -153.04 -314.925 30.586 -30.143
Diluted Weighted Average Shares 550.847 559.161 563.144 595.454 640.655 648.078
Diluted EPS Excluding Extraordinary Items -0.08779 -0.54591 -0.27176 -0.52888 0.04774 -0.04651
Diluted Normalized EPS -0.07729 -0.52383 -0.24097 -0.42474 0.04874 -0.07811
Total Extraordinary Items 0
Total Adjustments to Net Income 0.001
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 545.165 442.408 385.813 401.331 329.219
Revenue 545.165 442.408 385.813 401.331 329.219
Cost of Revenue, Total 363.507 292.908 243.957 292.823 243.875
Gross Profit 181.658 149.5 141.856 108.508 85.344
Total Operating Expense 506.728 436.837 347.987 464.415 401.643
Selling/General/Admin. Expenses, Total 112.286 113.236 105.12 138.214 117.537
Research & Development 19.315 18.222 18.306 21.007 18.312
Depreciation / Amortization 12.577 12.574 12.609 12.518 22.025
Other Operating Expenses, Total -0.957 -0.103 -0.497 -0.147 -0.106
Operating Income 38.437 5.571 37.826 -63.084 -72.424
Interest Income (Expense), Net Non-Operating -5.829 -5.153 -2.998 -4.026 -2.784
Other, Net -0.927 -11.783 -3.356 1.297 -1.442
Net Income Before Taxes 31.681 -11.365 31.472 -65.813 -76.65
Net Income After Taxes 31.121 -16.119 28.792 -73.309 -55.384
Equity In Affiliates -0.043 -0.067 -0.053 -0.466 -0.049
Net Income Before Extra. Items 31.078 -16.186 28.739 -73.775 -55.433
Net Income 31.078 -16.186 28.739 -73.775 -55.433
Income Available to Common Excl. Extra. Items 31.078 -16.186 28.739 -73.774 -55.433
Income Available to Common Incl. Extra. Items 31.078 -16.186 28.739 -73.774 -55.433
Diluted Net Income 31.078 -16.186 28.739 -73.774 -55.433
Diluted Weighted Average Shares 640.853 646.997 651.843 652.18 660.302
Diluted EPS Excluding Extraordinary Items 0.04849 -0.02502 0.04409 -0.11312 -0.08395
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.04849 -0.02502 0.01267 -0.11312 -0.08395
Unusual Expense (Income) -31.508 0
Total Adjustments to Net Income 0.001
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 483.601 348.861 317.731 324.045 523.179 823.013
Cash and Short Term Investments 168.733 91.499 96.473 85.452 72.211 134.71
Cash & Equivalents 168.733 91.499 96.473 85.452 72.211 134.71
Total Receivables, Net 249.492 192.892 161.983 157.687 302.256 265.588
Accounts Receivable - Trade, Net 220.284 165.516 143.907 134.617 286.314 259.637
Total Inventory 47.228 49.333 42.299 53.434 132.341 86.502
Prepaid Expenses 10.64 11.739 13.129 11.633 11.062 15.024
Other Current Assets, Total 7.508 3.398 3.847 15.839 5.309 321.189
Total Assets 2766.62 2589.96 2451.07 2309.27 2473.06 2399.72
Property/Plant/Equipment, Total - Net 122.831 146.557 144.674 166.491 178.289 123.955
Property/Plant/Equipment, Total - Gross 79.509 232.404 256.336 302.936 343.058 257.281
Accumulated Depreciation, Total -56.778 -85.847 -111.662 -136.445 -164.769 -133.326
Goodwill, Net 704.603 717.099 700.193 671.94 680.602 520.601
Intangibles, Net 1408.69 1331.18 1250.02 1119.16 1065.2 911.883
Long Term Investments 37.122 37.309 30.373 20.626 15.731 10.729
Other Long Term Assets, Total 9.773 8.948 8.077 7.008 10.06 9.534
Total Current Liabilities 263.296 312.029 288.321 249.119 375.483 330.008
Accounts Payable 53.36 74.307 47.395 62.537 100.883 82.04
Accrued Expenses 117.066 160.588 133.476 154.891 231.661 202.602
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 15.006 15.325 40.693 12.362 27.156 16.952
Other Current Liabilities, Total 77.864 61.809 66.757 19.329 15.783 28.414
Total Liabilities 674.811 746.333 659.781 694.513 801.512 714.589
Total Long Term Debt 73.707 142.665 172.771 263.909 228.631 193.083
Long Term Debt 66.491 134.879 167.151 259.863 225.826 190.159
Capital Lease Obligations 7.216 7.786 5.62 4.046 2.805 2.924
Deferred Income Tax 165.331 148.729 115.193 118.717 137.208 148.487
Other Liabilities, Total 172.477 142.91 83.496 62.768 60.19 43.011
Total Equity 2091.81 1843.62 1791.29 1614.76 1671.55 1685.13
Common Stock 5.586 5.6 5.869 6.704 6.706 6.901
Additional Paid-In Capital 2845.1 2889.26 3004.42 3142.99 3152.69 3222.49
Retained Earnings (Accumulated Deficit) -729.954 -1048.91 -1197.08 -1511.08 -1481.83 -1511.98
Treasury Stock - Common -1.911 -1.791 -1.791 -1.791 -1.791 -1.791
Unrealized Gain (Loss) -0.263 4.876 0
Other Equity, Total -26.746 -5.404 -20.131 -22.07 -4.225 -30.495
Total Liabilities & Shareholders’ Equity 2766.62 2589.96 2451.07 2309.27 2473.06 2399.72
Total Common Shares Outstanding 557.989 559.474 586.332 669.829 670.036 681.427
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 599.049 547.029 557.51 823.013 754.069
Cash and Short Term Investments 89.503 65.757 148.599 134.71 102.281
Cash & Equivalents 89.503 65.757 148.599 134.71 102.281
Total Receivables, Net 330.293 275.639 265.527 265.588 221.295
Accounts Receivable - Trade, Net 320.462 265.856 255.192 259.637 212.755
Total Inventory 159.104 134.722 112.861 86.502 99.406
Prepaid Expenses 15.086 21.967 19.52 15.024 9.902
Other Current Assets, Total 5.063 48.944 11.003 321.189 321.185
Total Assets 2519.57 2421.65 2417.64 2399.72 2306.86
Property/Plant/Equipment, Total - Net 177.7 143.001 141.002 123.955 124.667
Goodwill, Net 676.162 677.36 674.574 520.601 519.052
Intangibles, Net 1046.51 1035.71 1024.06 911.883 890.498
Long Term Investments 10.41 8.945 11.753 10.729 9.472
Other Long Term Assets, Total 9.745 9.6 8.744 9.534 9.1
Total Current Liabilities 403.93 303.98 283.035 330.008 309.17
Accounts Payable 162.69 88.512 94.393 82.04 94.24
Accrued Expenses 206.106 186.79 168.936 202.602 166.297
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 20.103 20.045 16.702 16.952 19.863
Other Current Liabilities, Total 15.031 8.633 3.004 28.414 28.77
Total Liabilities 823.061 679.065 652.071 714.589 691.974
Total Long Term Debt 230.613 189.727 189.516 193.083 216.358
Long Term Debt 228.107 187.168 187.214 190.159 212.493
Capital Lease Obligations 2.506 2.559 2.302 2.924 3.865
Deferred Income Tax 135.244 136.416 134.247 148.487 125.03
Other Liabilities, Total 53.274 48.942 45.273 43.011 41.416
Total Equity 1696.51 1742.58 1765.57 1685.13 1614.88
Common Stock 6.707 6.898 6.9 6.901 6.902
Additional Paid-In Capital 3155.65 3214.35 3218.58 3222.49 3191.14
Retained Earnings (Accumulated Deficit) -1450.76 -1466.94 -1438.2 -1511.98 -1549.95
Treasury Stock - Common -1.791 -1.791 -1.791 -1.791 -1.791
Other Equity, Total -13.295 -9.932 -19.923 -30.495 -31.415
Total Liabilities & Shareholders’ Equity 2519.57 2421.65 2417.64 2399.72 2306.86
Total Common Shares Outstanding 670.153 681.163 681.342 681.427 681.483
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -48.359 -305.25 -153.04 -314.925 30.586 -30.143
Cash From Operating Activities 32.046 -92.08 -109.141 -172.522 39.476 38.337
Cash From Operating Activities 96.576 102.093 97.344 93.807 85.362 78.716
Deferred Taxes -66.3 16.092 -35.133 4.324 15.64 10.159
Non-Cash Items 70.062 46.633 39.832 113.079 5.497 0.087
Cash Taxes Paid -27.122 5.416 1.41 -2.667 0.903 5.969
Cash Interest Paid 2.89 1.313 2.076 11.873 10.908 8.515
Changes in Working Capital -19.933 48.352 -58.144 -68.807 -97.609 -20.482
Cash From Investing Activities -20.702 -46.667 -26.119 -13.27 -18.327 35.949
Capital Expenditures -23.547 -46.524 -27.858 -12.741 -33.682 -32.156
Other Investing Cash Flow Items, Total 2.845 -0.143 1.739 -0.529 15.355 68.105
Cash From Financing Activities -35.195 61.043 140.909 175.248 -35.076 -10.351
Issuance (Retirement) of Stock, Net 8.576 2.132 148.673 276.352 0.756 1.08
Issuance (Retirement) of Debt, Net -43.771 58.911 -7.764 -93.342 -35.832 -11.243
Foreign Exchange Effects -1.014 0.47 -0.675 -0.477 0.686 -1.436
Net Change in Cash -24.865 -77.234 4.974 -11.021 -13.241 62.499
Financing Cash Flow Items -7.762 0 -0.188
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 31.078 14.892 43.631 -30.143 -55.433
Cash From Operating Activities 26.037 10.584 43.98 38.337 -19.856
Cash From Operating Activities 19.989 40.561 59.525 78.716 27.814
Deferred Taxes -1.033 2.479 2.378 10.159 -22.356
Non-Cash Items 1.222 19.401 -9.952 0.087 9.879
Cash Taxes Paid 1.47 3.69 5.509 5.969 1.063
Cash Interest Paid 4.689 4.883 8.386 8.515 3.42
Changes in Working Capital -25.219 -66.749 -51.602 -20.482 20.24
Cash From Investing Activities -1.106 -9.948 44.628 35.949 -4.903
Capital Expenditures -9.245 -18.192 -25.426 -32.156 -5.251
Other Investing Cash Flow Items, Total 8.139 8.244 70.054 68.105 0.348
Cash From Financing Activities -7.192 -6.927 -11.183 -10.351 -7.891
Issuance (Retirement) of Stock, Net 0.308 0.466 0.879 1.08 0.136
Issuance (Retirement) of Debt, Net -7.5 -7.393 -11.874 -11.243 -8.027
Foreign Exchange Effects -0.447 -0.163 -1.037 -1.436 0.221
Net Change in Cash 17.292 -6.454 76.388 62.499 -32.429
Financing Cash Flow Items -0.188 -0.188
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Frost Gamma Investments Trust Corporation 26.405 204027475 200000 2022-11-23 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.2039 40209654 -2296471 2022-09-30 LOW
Holbrook (Bruce C) Individual Investor 5.1484 39781126 39781126 2022-05-10
Hsiao (Jane H) Individual Investor 4.2355 32727274 0 2022-07-28
Frost Group, L.L.C. Corporation 3.899 30127177 0 2022-08-17 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.8394 29666569 -351756 2022-09-30 LOW
GJN 2021 Trust Corporation 2.5699 19857514 19857514 2022-06-22
EGN 2021 Trust Corporation 2.5699 19857514 19857514 2022-06-22
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.4008 10823641 1744961 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3426 10374273 507764 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.0132 7829188 200456 2022-09-30 LOW
Rubin (Steven D) Individual Investor 0.7969 6157732 0 2022-05-23
D. E. Shaw & Co., L.P. Hedge Fund 0.7724 5968306 -397910 2022-09-30 MED
Oracle Investment Management, Inc. Investment Advisor/Hedge Fund 0.6604 5102756 -2150000 2022-09-30 MED
Two Sigma Investments, LP Hedge Fund 0.6484 5009766 2467029 2022-09-30 HIGH
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.5534 4276383 1215448 2021-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.4935 3813530 420857 2022-09-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.4461 3446571 -87509 2022-09-30 LOW
Invesco Capital Management LLC Investment Advisor 0.4186 3234077 709875 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 0.3671 2836343 -1053829 2022-09-30 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+485000+

Trader

65000+

Klien aktif per bulan

$48000000+

Volume investasi per bulan

$28000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Pharmaceuticals (NEC)

4400 Biscayne Blvd.
MIAMI
FLORIDA 33137
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,824.20 Price
+2.790% 1D Chg, %
Biaya inap posisi Long -0.0174%
Biaya inap posisi short 0.0068%
Waktu biaya inap 22:00 (UTC)
Spread 1.8

Oil - Crude

77.02 Price
-0.170% 1D Chg, %
Biaya inap posisi Long -0.0204%
Biaya inap posisi short 0.0049%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

XRP/USD

0.42 Price
+1.000% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 0.00352

Natural Gas

2.49 Price
-0.400% 1D Chg, %
Biaya inap posisi Long -0.0885%
Biaya inap posisi short 0.0595%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 485.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda